Learn More
Medchemexpress LLC WJ-39 | 3009908-95-3 | >99.6% | 430.32 | 100 MG

Supplier: Medchemexpress LLC HY162325100MG
WJ-39 is an orally active aldose reductase (AR) inhibitor. It improves tubular damage in diabetic nephropathy rats by activating PINK1/Parkin signaling, promoting mitophagy, and attenuating apoptosis.
- Orally active aldose reductase (AR) inhibitor.
- Ameliorates renal tubular injury in diabetic nephropathy.
- Activates PINK1/Parkin signaling.
- Promotes mitophagy.
- Attenuates apoptosis.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.